The differential effects of PGE on the immune response in normal and immunosuppressed mice.
D015064:16,16-Dimethylprostaglandin E2 / Q000494:pharmacology*; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000921:Antibody-Producing Cells; D000961:Antilymphocyte Serum / Q000494:pharmacology; D002452:Cell Count; D002471:Cell Transformation, Neoplastic / Q000187:drug effects / Q000276:immunology; D004317:Doxorubicin / Q000494:pharmacology; D005260:Female; D006388:Hemagglutinins / Q000032:analysis; D007111:Immunity, Cellular / Q000187:drug effects; D007165:Immunosuppression Therapy; D008545:Melanoma / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology*; D011817:Rabbits; D013156:Splenectomy; D013601:T-Lymphocytes / Q000276:immunology; D013934:Thymectomy
D000961:Antilymphocyte Serum; D006388:Hemagglutinins; D011459:Prostaglandins E, Synthetic; D004317:Doxorubicin; D015064:16,16-Dimethylprostaglandin E2